MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

DexCom Inc

Fermé

SecteurSoins de santé

61.78 -9.45

Résumé

Variation du prix de l'action

24h

Actuel

Min

61.47

Max

68.09

Chiffres clés

By Trading Economics

Revenu

17M

152M

Ventes

119M

1.1B

P/E

Moyenne du Secteur

47.409

63.778

BPA

0.45

Marge bénéficiaire

13.624

Employés

10,200

EBITDA

5M

242M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+53.59% upside

Dividendes

By Dow Jones

Prochains Résultats

24 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-7.9B

26B

Ouverture précédente

71.23

Clôture précédente

61.78

Sentiment de l'Actualité

By Acuity

15%

85%

26 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

DexCom Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 oct. 2024, 09:10 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 juil. 2024, 20:16 UTC

Résultats

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 juil. 2024, 09:13 UTC

Actualités
Actions en Tendance

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 juil. 2024, 08:56 UTC

Actualités

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 juin 2024, 16:01 UTC

Résultats

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Comparaison

Variation de prix

DexCom Inc prévision

Objectif de Prix

By TipRanks

53.59% hausse

Prévisions sur 12 Mois

Moyen 103.4 USD  53.59%

Haut 120 USD

Bas 82 USD

Basé sur 18 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

18 ratings

16

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

66.25 / 72.47Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

26 / 386Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.